GL1X · GenesisL1 explorer

MolNFT v1 · #138578 · protein

Crystal structure of murine receptor-interacting protein 4 (RIPK4) D143N bound to tozasertib (vx-680)

5WNM · Receptor-interacting SERINE/THREONINE-protein kinase 4: “Crystal structure of murine receptor-interacting protein 4 (RIPK4) D143N bound to tozasertib (vx-680)”. X-ray diffraction, 2 ligands (VX6, CL), 2 pockets (best druggability…

PDB
5WNM
Type
protein
Length
263 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Receptor-interacting SERINE/THREONINE-protein kinase 4
EC
2.7.11.1
UniProt
Q9ERK0
Ligands
VX6, CL
Pockets
2 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReceptor-interacting SERINE/THREONINE-protein kinase 4 (EC 2.7.11.1)protein26342% helix, 16% strandQ9ERK0

Ligands and binding sites

  • VX6 · Cyclopropanecarboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidin-2-ylsulfanyl]-phenyl}-amide · ligand · chains A
  • CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12890.630.8030VX6
21220.490.7930empty

Compared structures

  • 5WNM · Crystal structure of murine receptor-interacting protein 4 (Ripk4) D143N bound to… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9ERK0 · AlphaFold monomer V2.0 prediction for receptor-interacting SERINE/THREONINE-protein… · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.